NVIV - InVivo Therapeutics Holdings Corp.

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 53.61M
Enterprise Value 3-6.7M
Trailing P/E N/A
Forward P/E 1-1.61
PEG Ratio (5 yr expected) 1N/A
Price/Sales (ttm)N/A
Price/Book (mrq)0.35
Enterprise Value/Revenue 3N/A
Enterprise Value/EBITDA 60.38

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2017
Most Recent Quarter (mrq)Jun 30, 2018


Profit Margin 0.00%
Operating Margin (ttm)0.00%

Management Effectiveness

Return on Assets (ttm)-46.76%
Return on Equity (ttm)-372.06%

Income Statement

Revenue (ttm)N/A
Revenue Per Share (ttm)N/A
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)N/A
EBITDA -17.55M
Net Income Avi to Common (ttm)-31.74M
Diluted EPS (ttm)-18.55
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)22.32M
Total Cash Per Share (mrq)2.88
Total Debt (mrq)330k
Total Debt/Equity (mrq)N/A
Current Ratio (mrq)0.92
Book Value Per Share (mrq)5.33

Cash Flow Statement

Operating Cash Flow (ttm)-15.48M
Levered Free Cash Flow (ttm)14.97M

Trading Information

Stock Price History

Beta 2.50
52-Week Change 3-93.79%
S&P500 52-Week Change 316.20%
52 Week High 356.25
52 Week Low 31.63
50-Day Moving Average 31.97
200-Day Moving Average 38.03

Share Statistics

Avg Vol (3 month) 3329.02k
Avg Vol (10 day) 3118.05k
Shares Outstanding 51.95M
Float 5.76M
% Held by Insiders 10.71%
% Held by Institutions 135.01%
Shares Short (Jul 13, 2018) 4193.96k
Short Ratio (Jul 13, 2018) 40.27
Short % of Float (Jul 13, 2018) 412.42%
Short % of Shares Outstanding (Jul 13, 2018) 46.41%
Shares Short (prior month Jun 15, 2018) 4237.11k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor (new per old) 21/25
Last Split Date 3Apr 17, 2018